Kimberly Stegmaier appointed chair of pediatric oncology at Dana-Farber

Jason Damsker and Michael Noonan join Fox Chase

Jason A. DamskerMichael NoonanJason A. Damsker was appointed professor in the Department of Hematology/Oncology and Michael Noonan was appointed assistant professor in the Supportive Oncology and Palliative Care Program at Fox Chase Cancer Center.

February 21, 2025

Vol.51 No.07

In Brief

Children’s National Hospital, Virginia Tech expand partnership for pediatric cancer research

Children’s National Hospital and Virginia Tech are expanding their research partnership, building on a successful collaboration established in 2019.

February 14, 2025

Vol.51 No.06

Drugs & Targets

FDA approves Gomekli for pediatric patients with neurofiromatosis type 1

FDA approved Gomekli (mirdametinib), a kinase inhibitor from SpringWorks Therapeutics, for adult and pediatric patients two years of age and older with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas not amenable to complete resection.

February 14, 2025

Vol.51 No.06

Clinical Roundup

Cancer vaccine shows promise for patients with stage 3 and 4 kidney cancer

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage 3 or 4 clear cell renal cell carcinoma generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.

February 07, 2025

Vol.51 No.05

Clinical Trials & Tribulations

From clinician scientist to nonprofit CEO

I was a practicing pediatric hematologist oncologist and researcher for 21 years. As a doctor, it was a tremendous privilege to be invited into the lives of patients and families dealing with blood cancers and be entrusted with their care. As a researcher, it was incredibly rewarding to help bring more effective blood cancer therapies to kids.

DFCI researchers use PET imaging to detect body inflammation

Researchers at Dana-Farber Cancer Institute developed a method to detect inflammation in the body using positron emission tomography imaging. This innovative probe targets CD45, a marker abundantly expressed on all immune cells but absent from other cell types.

January 24, 2025

Vol.51 No.03

Kimberly Stegmaier appointed chair of pediatric oncology at Dana-Farber

YOU MAY BE INTERESTED IN

Jason Damsker and Michael Noonan join Fox Chase

Children’s National Hospital, Virginia Tech expand partnership for pediatric cancer research

FDA approves Gomekli for pediatric patients with neurofiromatosis type 1

Cancer vaccine shows promise for patients with stage 3 and 4 kidney cancer

From clinician scientist to nonprofit CEO

DFCI researchers use PET imaging to detect body inflammation

Renew today!

Subscriber content

Never miss an issue!

Login